Related references
Note: Only part of the references are listed.In PD-1+human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies
Caterina Ierano et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy
Juan Du et al.
FRONTIERS IN ONCOLOGY (2022)
Genome-Wide Association and Transcriptome-Wide Association Studies Identify Novel Susceptibility Genes Contributing to Colorectal Cancer
Ruimin Yin et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2022)
CDC7 as a novel biomarker and druggable target in cancer
Runze Liu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)
Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib
Sina Sender et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Upregulation of CDC7 Associated with Cervical Cancer Incidence and Development
Qingwei Wang et al.
BIOMED RESEARCH INTERNATIONAL (2021)
A nine-gene signature to improve prognosis prediction of colon carcinoma
Jinlai Zhao et al.
CELL CYCLE (2021)
Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells
Yuwei Liu et al.
GENOMICS (2021)
RANK promotes colorectal cancer migration and invasion by activating the Ca2+-calcineurin/NFATC1-ACP5 axis
Qian Liang et al.
CELL DEATH & DISEASE (2021)
Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer
Yingyan Han et al.
EPIGENETICS (2020)
Membranous overexpression of S100A10 is associated with a high-grade cellular status of breast carcinoma
Kazumori Arai et al.
MEDICAL MOLECULAR MORPHOLOGY (2020)
The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment
Ekaterina Kim et al.
LEUKEMIA (2020)
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
George S. Sheppard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pan- and Isoform-specific Inhibition of the Bromodomain and Extra-terminal Proteins and Evaluation of Synergistic Potential With Entospletinib in Canine Lymphoma
Weibo Kong et al.
ANTICANCER RESEARCH (2020)
BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression
Thomas E. C. Cummin et al.
BLOOD ADVANCES (2020)
LEF1 Induces DHRS2 Gene Expression in Human Acute Leukemia Jurkat T-Cells
Sema Sirma Ekmekci et al.
TURKISH JOURNAL OF HEMATOLOGY (2020)
S100A10 Accelerates Aerobic Glycolysis and Malignant Growth by Activating mTOR-Signaling Pathway in Gastric Cancer
Yan Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Targeting BET bromodomain proteins in cancer: The example of lymphomas
Filippo Spriano et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases
Chunyuan Li et al.
JOURNAL OF CANCER (2020)
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2
Tomoko Takimoto-Shimomura et al.
INVESTIGATIONAL NEW DRUGS (2019)
The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
Yang Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
GPR124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation
Allison E. Cherry et al.
GLIA (2019)
Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients
Lukasz Pietrzyk et al.
ADVANCES IN MEDICAL SCIENCES (2019)
The prognostic value of S100A10 expression in cancer
Normastuti Adhini Tantyo et al.
ONCOLOGY LETTERS (2019)
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani et al.
FUTURE SCIENCE OA (2019)
DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma
Y. Zhou et al.
ONCOGENE (2018)
AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis
Matt Teater et al.
NATURE COMMUNICATIONS (2018)
Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation
Leila Taher et al.
SCIENTIFIC REPORTS (2018)
BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors
Enrico Derenzini et al.
CELL REPORTS (2018)
Microarray data of transcriptome shifts in blood cell subsets during S1P receptor modulator therapy
Dirk Koczan et al.
SCIENTIFIC DATA (2018)
The Human Replicative Helicase, the CMG Complex, as a Target for Anti-cancer Therapy
Yeon-Soo Seo et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
Keith F. McDaniel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
Fei Ouyang et al.
ONCOLOGY REPORTS (2017)
Genome-wide gene expression array identifies novel genes related to disease severity and excessive daytime sleepiness in patients with obstructive sleep apnea
Yung-Che Chen et al.
PLOS ONE (2017)
KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression
Dong Ma et al.
SCIENTIFIC REPORTS (2017)
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J. Hogg et al.
CELL REPORTS (2017)
Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia
Dan Huang et al.
FRONTIERS OF MEDICINE (2017)
Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma
Elena Bernasconi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
MCM5 as a target of BET inhibitors in thyroid cancer cells
Catia Mio et al.
ENDOCRINE-RELATED CANCER (2016)
RANK as a therapeutic target in cancer
Eva Gonzalez-Suarez et al.
FEBS JOURNAL (2016)
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
Brian K. Albrecht et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies
Garrett W. Rhyasen et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Hsa-miR-495 acts as a tumor suppressor gene in glioma via the negative regulation of MYB
Benping Zhang et al.
MOLECULAR MEDICINE REPORTS (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells
S. V. Muralidharan et al.
ONCOGENE (2016)
Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib
Baohua Sun et al.
BLOOD (2015)
Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibition
Steven Tinsley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Analysis of drug combinations: current methodological landscape
Julie Foucquier et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
G-Protein Coupled Receptor 124 (GPR124) in Endothelial Cells Regulates Vascular Endothelial Growth Factor (VEGF)-Induced Tumor Angiogenesis
Y. Wang et al.
CURRENT MOLECULAR MEDICINE (2014)
Gpr124 Controls CNS Angiogenesis and Blood-Brain Barrier Integrity by Promoting Ligand-Specific Canonical Wnt Signaling
Yulian Zhou et al.
DEVELOPMENTAL CELL (2014)
Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer- associated variants
Vanya D. Peltekova et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb
Lei Yu et al.
PLOS ONE (2014)
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
Bjoern Chapuy et al.
CANCER CELL (2013)
Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents
An Ning Cheng et al.
CANCER LETTERS (2013)
Protein interaction and cellular localization of human CDC45
Junichiro Takaya et al.
JOURNAL OF BIOCHEMISTRY (2013)
Role and potential for therapeutic targeting of MYB in leukemia
D. R. Pattabiraman et al.
LEUKEMIA (2013)
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity
X. Zhao et al.
LEUKEMIA (2013)
Comparative Gene Expression Profiling Identifies Common Molecular Signatures of NF-κB Activation in Canine and Human Diffuse Large B Cell Lymphoma (DLBCL)
Manikhandan A. V. Mudaliar et al.
PLOS ONE (2013)
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
Melanie R. Hassler et al.
EPIGENOMICS (2013)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
RANK (TNFRSF11A) Is Epigenetically Inactivated and Induces Apoptosis in Gliomas
Anna von dem Knesebeck et al.
NEOPLASIA (2012)
SYK inhibition and response prediction in diffuse large B-cell lymphoma
Shuhua Cheng et al.
BLOOD (2011)
Evidence for a link between TNFRSF11A and risk of breast cancer
Nuria Bonifaci et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Jennifer A. Mertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Activation of the MCM2-7 Helicase by Association with Cdc45 and GINS Proteins
Ivar Ilves et al.
MOLECULAR CELL (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Essential Regulation of CNS Angiogenesis by the Orphan G Protein-Coupled Receptor GPR124
Frank Kuhnert et al.
SCIENCE (2010)
The SYK tyrosine kinase: a crucial player in diverse biological functions
Attila Mocsai et al.
NATURE REVIEWS IMMUNOLOGY (2010)
The Mcm Complex: Unwinding the Mechanism of a Replicative Helicase
Matthew L. Bochman et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2009)
MYB function in normal and cancer cells
Robert G. Ramsay et al.
NATURE REVIEWS CANCER (2008)
Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis
EC Obermann et al.
BMC CANCER (2005)
Microarray analysis of B-cell lymphoma cell lines with the t(14;18)
RS Robetorye et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2002)
Pleckstrin homology domains and the cytoskeleton
MA Lemmon et al.
FEBS LETTERS (2002)
The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase Gcn5p
DJ Owen et al.
EMBO JOURNAL (2000)
Share Paper
